Avoro Capital Advisors LLC Q3 2017 Filing

Filed November 14, 2017

Portfolio Value

$1.3T

Holdings

40

Report Date

Q3 2017

Filing Type

13F-HR

All Holdings (40 positions)

#StockSharesValue% PortfolioType
1
IMMUNOMEDICS INC
15,614,461$212.4B16.47%Call
2
AM6AMICUS THERAPEUTICS INC
9,437,122$105.5B8.18%Call
3
KITE PHARMA INC
496,983$89.4B6.93%
4
ARRYEURARRAY BIOPHARMA INC
5,853,029$67.3B5.22%Call
5
CLVSEURCLOVIS ONCOLOGY INC
785,700$64.7B5.02%
6
MEDICINES CO
1,720,393$63.7B4.94%
7
ASNDASCENDIS PHARMA
1,636,124$59.3B4.60%
8
BMRNBIOMARIN PHARMACEUTICAL INC
597,972$55.7B4.32%
9
PCRXPACIRA PHARMACEUTICALS INC
1,311,460$49.2B3.82%
10
HORIZON PHARMA PLC
3,516,100$44.6B3.46%
11
MRTXEURMIRATI THERAPEUTICS INC
3,710,601$43.4B3.37%
12
AVEXIS INC
436,702$42.2B3.28%
13
DERMIRA INC
1,520,000$41.0B3.18%
14
ZOGENIX INC
1,026,368$36.0B2.79%
15
GBTUSDGLOBAL BLOOD THERAPEUTICS INC
1,124,300$34.9B2.71%
16
IOVAIOVANCE BIOTHERAPEUTICS INC
4,201,343$32.6B2.53%
17
ASMBASSEMBLY BIOSCIENCES INC
907,162$31.7B2.46%
18
TELIGENT INC
4,578,230$30.7B2.38%
19
TESARO INC
195,092$25.2B1.95%
20
INTEC PHARMA LTD
2,195,705$19.7B1.52%
21
VNDAVANDA PHARMACEUTICALS INC
988,270$17.7B1.37%
22
AVEO PHARMACEUTICALS INC
4,806,249$17.5B1.36%
23
MYOKARDIA INC
398,207$17.1B1.32%
24
CPRXCATALYST PHARMACEUTICALS INC
4,635,745$11.7B0.91%
25
AGENEURAGENUS INC
2,459,554$10.8B0.84%
26
ARGXARGENX SE
429,600$9.7B0.75%
27
BCRXBIOCRYST PHARMACEUTICALS INC
1,778,525$9.3B0.72%
28
ALIMERA SCIENCES INC
6,241,581$8.4B0.65%
29
VCYTVERACYTE INC
936,909$8.2B0.64%
30
DBV TECHNOLOGIES S A
193,600$8.2B0.64%
31
CASCADIAN THERAPEUTICS INC
1,821,248$7.4B0.58%
32
VIVEVE MEDICAL INC
1,033,276$5.4B0.42%
33
PERNIX THERAPEUTICS HOLDINGS INC
6,000,000$2.5B0.20%
34
CLLSCELLECTIS S A
78,289$2.2B0.17%
35
OVASCIENCE INC
1,121,952$1.6B0.12%
36
ONCOBIOLOGICS INC
683,531$936.0M0.07%
37
FRXFENNEC PHARMACEUTICALS INC
66,666$731.0M0.06%
38
SPYSPDR S&P 500 ETF
250,000$469.0M0.04%Put
39
ONCOBIOLOGICS INC - WARRANT A
233,333$28.0M0.00%
40
ONCOBIOLOGICS INC - WARRANT B
233,333$12.0M0.00%